Related Experiment Video

Updated: May 22, 2026

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells
12:46

Flow Cytometry-Based Quantification and Analysis of Myocardial B-Cells

Published on: August 17, 2022

Idiopathic dilated cardiomyopathy: possible triggers and treatment strategies

M Hazebroek1, R Dennert, S Heymans

  • 1Department of Cardiology, CARIM, University Hospital Maastricht, Maastricht, the Netherlands.

Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|May 24, 2012
PubMed

Insights

Idiopathic dilated cardiomyopathy (DCM) diagnosis is improving with new molecular and genetic techniques. These advancements offer novel, cause-specific treatments and better outcomes for heart failure patients.

Area of Science:

  • Cardiology and cardiovascular diseases.
  • Molecular pathology and diagnostics.

Background:

  • High morbidity and mortality persist in heart failure patients despite treatment advances.
  • Idiopathic dilated cardiomyopathy (DCM) accounts for up to 50% of heart failure cases with unknown etiology.
  • Traditional causes include ischemic heart disease, hypertension, and valvular disease.

Purpose of the Study:

  • To discuss the causes of dilated cardiomyopathy (DCM).
  • To highlight advancements in diagnosing idiopathic DCM.
  • To focus on inflammatory and virus-mediated DCM.

Main Methods:

  • Review of current diagnostic advancements in DCM.
  • Focus on molecular and immunohistological biopsy techniques.
  • Emphasis on genetic research in idiopathic DCM.

Main Results:

  • Improved diagnostic accuracy for idiopathic DCM.
  • Emergence of novel, etiology-based treatment strategies.
  • Potential for improved patient outcomes through targeted therapies.

Conclusions:

  • Advancements in molecular and genetic diagnostics are revolutionizing idiopathic DCM classification.
  • Etiology-based treatments are emerging as a key strategy for improving outcomes.
  • Inflammatory and viral causes are significant contributors to DCM and warrant focused investigation.

More Related Videos

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo05:14

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo

Published on: May 16, 2020

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice04:45

Real-Time Electrocardiogram Monitoring During Treadmill Training in Mice

Published on: May 5, 2022

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...